At the same time, in my other blogs, there are other synthetic methods of this type of compound,945950-37-8, 4-Methyl-7H-pyrrolo[2,3-d]pyrimidine, and friends who are interested can also refer to it.
Application of 945950-37-8, Researchers who often do experiments know that organic synthesis is a process of preparing more complex target molecules from simple raw materials through one or more chemical reactions. Generally, it requires fewer steps,and cheap raw materials. 945950-37-8, name is 4-Methyl-7H-pyrrolo[2,3-d]pyrimidine. A new synthetic method of this compound is introduced below.
Step 3: To a stirred solution of (3R,3aS,6aR}-6-((2-ainino-3-fiuoroquinolin-7- yl)methvi)hexahydro-2H-cyclopenta[b]furan-2,3,3a-trioi (0.067 g. 0.2 mmoi) in dry MeCN (3 rnL) was added trihutyiphosphine (0.077 g, 0.38 rnmol), followed by (E)-diazene-1,2- diylbis(piperidin-1-yimethanone) (0.091 g, 0.36 minol) at room temperature. The reactionmixture was stirred at room temperature for 1 h. Separately, to a stirred solution of 4-rnethyl-7H- pvrroio[2,3-d]pyrimidine (0.053 g, 0.400 mmoi) in dry DMF (2 mE) was added NaH (0.024 g, 60% in mineral oil, 0.600 mmoi) at 0 The suspension was stirred at room temperature for 30 minutes. The suspension was then transferred to the solution originally containing the triol via syringe. The resulting reaction was stirred at room temperature for 2 Ii The reaction mixture wasthen quenched with saturated ammonium chloride (30 mE) and extracted with EtOAc (40 mL x3). The combined organic layers were washed with brine (40 mE), dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated under reduced pressure, and the resulting residue was purified by preparative TEC (1: 1 DCMIMeOH). The product was further purified by reverse phase column chromatography (ACN/water with 5 mM NH4HCO3 modifier) to afford(2R,3R,3aS,6S,6aR)-6-((2-ainino-3-fiuoroquinolin-7-yl)methyi}-2-(4-methyi-71-1-pyrrolo[2,3- d]pyrimidin-7-yi)hexalwdro-2H-cyclopenta[h]finan-3,3a-diol as a solid, MS: 450 (M + 1). ?HNMR (400 MHz, DMSO-d6) d 8.69 (s, 1H), 7.87 (d, 3 = 4.0 Hz, 1H), 7.74 (d, J = 11.6 Hz, IH), 7.52 (d, J 8.0 Hz, IH), 7.28 (s, 1H), 7.07 (d, 3:::: 8.0 Hz, 11-1), 6.82 (d, J =: 3.6 Hz, 1K), 6.66 (br s, 2H), 6.01 (d. J 8.0 Hz. 1H). 5.31 (d, J 7.2 FIz. 1K). 5,12 (s. 1K). 4,22 (d, J 7.6 FIz. il-i). 401 (d, J = 6.0 Hz, 1H), 2.84 – 2.79 (rn, 1H), 2.69 (5, 3H), 2.67 2.59 (in. IH), 2.28 2.22 (rn,1H), 1.98 1.94 (in. 11-1). 1.76 – 1.69 (rn, 2H), 1.58 1.53 (in. 1Ff).
At the same time, in my other blogs, there are other synthetic methods of this type of compound,945950-37-8, 4-Methyl-7H-pyrrolo[2,3-d]pyrimidine, and friends who are interested can also refer to it.
Reference:
Patent; MERCK SHARP & DOHME CORP.; IDENIX PHARMACEUTICALS LLC; MACHACEK, Michelle; WITTER, David; GIBEAU, Craig; HUANG, Chunhui; KAWAMURA, Shuhei; SLOMAN, David, L.; SILIPHAIVANH, Phieng; QUIROZ, Ryan; WAN, Murray; SCHNEIDER, Sebastian; YEUNG, Charles, S.; REUTERSHAN, Michael, H.; HENDERSON, Timothy, J.; PAPARIN, Jean-Laurent; RAHALI, Houcine; HUGHES, Jonathan, M., E.; SANYAL, Sulagna; YE, Yingchun; CANDITO, David, A.; FIER, Patrick, S.; SILVERMAN, Steven, M.; (277 pag.)WO2020/33288; (2020); A1;,
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia